Causal relationship between nitrogen dioxide and the risk of Parkinson's disease: Evidence from a Mendelian randomization study
- PMID: 40419892
- PMCID: PMC12114015
- DOI: 10.1097/MD.0000000000042582
Causal relationship between nitrogen dioxide and the risk of Parkinson's disease: Evidence from a Mendelian randomization study
Abstract
Several recent observational studies have found associations between nitrogen dioxide (NO2) exposure and the risk of Parkinson's disease (PD), but the causal relationship between them remains unclear. Our objective is to employ a 2-sample Mendelian randomization (MR) approach to determine the causal effect of NO2 exposure on the risk of PD. MR analyses were performed using genome-wide association studies (GWAS) data on NO2 exposure (n = 456,380) and PD GWAS data (33,674 cases and 449,056 controls). Inverse variance weighting (IVW) was the primary analytical method used to examine causal effects, coupled with the MR-Egger, weighted median, weighted model and MR pleiotropy residual sum and outlier (MR-PRESSO). The main results of the IVW method (odds ratio: 4.701; 95% CI: 1.127-19.615, P = .034) showed evidence for a causal relationship between NO2 exposure and the risk of PD. Heterogeneity analyses was conducted using the MR-Egger method (Cochran's Q = 1.155; P = .764) and IVW (Cochran's Q = 1.356; P = .852) demonstrated no statistically significant heterogeneity among the selected SNPs. We employed MR-Egger regression (β intercept = -0.026; SE = 0.058; P = .684) and the MR-PRESSO global test (P = .840), which revealed no significant impact of pleiotropy on the results of the MR evaluation. Based on MR analysis, higher levels of NO2 exposure are causally associated with an increased risk of PD. Consequently, mitigating air pollution could be an important strategy for reducing the risk of PD.
Keywords: Mendelian randomization; Parkinson’s disease; causal relationship; nitrogen dioxide; public health.
Copyright © 2025 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures
Similar articles
-
Association Between Serum Galectin-3 and Parkinson's Disease: A Two-Sample Mendelian Randomization Study.Brain Behav. 2024 Oct;14(10):e70103. doi: 10.1002/brb3.70103. Brain Behav. 2024. PMID: 39444071 Free PMC article.
-
Risk of Parkinson's disease and depression severity in different populations: A two-sample Mendelian randomization analysis.Brain Behav. 2024 Sep;14(9):e3642. doi: 10.1002/brb3.3642. Brain Behav. 2024. PMID: 39219304 Free PMC article.
-
[Genetic Causation Analysis of Hyperandrogenemia Testing Indicators and Preeclampsia].Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 May 20;55(3):566-573. doi: 10.12182/20240560106. Sichuan Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 38948277 Free PMC article. Chinese.
-
Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression.Mov Disord. 2021 Jun;36(6):1420-1429. doi: 10.1002/mds.28551. Epub 2021 Mar 8. Mov Disord. 2021. PMID: 33682937 Free PMC article.
-
Mendelian Randomization - the Key to Understanding Aspects of Parkinson's Disease Causation?Mov Disord. 2016 Apr;31(4):478-83. doi: 10.1002/mds.26492. Epub 2015 Dec 23. Mov Disord. 2016. PMID: 26695521 Free PMC article. Review.
References
-
- Borrageiro G, Haylett W, Seedat S, Kuivaniemi H, Bardien S. A review of genome-wide transcriptomics studies in Parkinson’s disease. Eur J Neurosci. 2018;47:1–16. - PubMed
-
- Jankovic J, Tan EK. Parkinson’s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry. 2020;91:795–808. - PubMed
-
- Dorsey ER, Bloem BR. The Parkinson pandemic a call to action. JAMA Neurol. 2018;75:9–10. - PubMed
-
- Limke A, Scharpf I, Blesing F, von Mikecz A. Tire components, age and temperature accelerate neurodegeneration in C. elegans models of Alzheimer’s and Parkinson’s disease. Environ Pollut. 2023;328:121660. - PubMed
-
- Jiang Y, Niu Y, Xia Y, et al. . Effects of personal nitrogen dioxide exposure on airway inflammation and lung function. Environ Res. 2019;177:108620. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical